All In MedTech

Device Trial Radar · NCT06387485

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

Last checked: Nov 20, 2026Latest source record: Feb 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

150

Planned (sponsor's estimate)

Start

Mar 1, 2024

Primary completion

Apr 30, 2027

Study completion Jul 31, 2027

Sponsor

Lead sponsor
Ricoh USA, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Apr 29, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 13 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This prospective, multi-center, randomized controlled study aims to assess the efficacy of utilizing 3D printed models in preoperative planning for the excision of tumors involving bony structures within the body. The study is expected to last approximately 12 months and involve up to 150 subjects across up to 5 sites. Subjects will be randomized in a 1:1 ratio into either the experimental arm, utilizing 3D printed models and imaging, or the active comparator arm, using only imaging. Primary endpoint: Operative time of surgical procedure. Secondary endpoints: Reduction of blood loss, proportion of postoperative adverse events, and negative tumor margins. Exploratory endpoints: Surgical planning ease, changes in surgical plan, and surgeon satisfaction.

Conditions

  • Sarcoma, Ewing
  • Chondrosarcoma
  • Osteosarcoma
  • Fibrous Histiocytoma
  • Fibrosarcoma

Interventions

  • 3D Printed Anatomic ModelDevice

    Patient-specific 3D printed anatomic model for pre-surgical planning

  • CT/MRIDiagnostic test

    Standard imaging type for bony tumors

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Operative timeTime frame: Incision to closure

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Kaiser Permanente Oakland Medical Center

    Oakland, California · Recruiting

  • William Beaumont University Hospital

    Royal Oak, Michigan · Recruiting

  • The Ohio State University Wexner Medical Center

    Columbus, Ohio · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.